RaySearch Laboratories (Q1 Initial take): Softer than expected but comforting updated financial target - Redeye
RaySearch came in softer than we expected on sales and EBIT (but in line with consensus EBIT). The updated financial targets should mitigate a negative share price reaction today, but we suspect it will hold it back from more than c2-3% up.
ANNONS
RaySearch came in softer than we expected on sales and EBIT (but in line with consensus EBIT). The updated financial targets should mitigate a negative share price reaction today, but we suspect it will hold it back from more than c2-3% up.